Chinese medicine Buyang Huanwu decoction promotes neurogenesis and angiogenesis in ischemic stroke rats by upregulating miR-199a-5p expression
OBJECTIVE: To investigate the mechanism of Chinese medicine Buyang Huanwu decoction (BYHWD) promoting neurogenesis and angiogenesis in ischemic stroke rats.
METHODS: Male SD rats were randomly divided into sham operation group, model group, BYHWD group, antagonist group and antagonist control group with 14 rats in each. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery for 90 min with intraluminal filament and reperfusion for 14 d in all groups except sham operation group. BYHWD (13 g/kg) was administrated by gastrogavage in BYHWD group, antagonist group and antagonist control group at 24 h after modeling respectively, and BrdU (50 mg/kg) was injected intraperitoneally in all groups once a day for 14 consecutive days. miR-199a-5p antagomir or NC (10 nmol) was injected into the lateral ventricle at d5 after ischemia in antagonist and antagonist control groups, respectively. The neurological deficits were evaluated by the modified neurological severity score (mNSS) and the corner test, and the infract volume was measured by toluidine blue staining. Neurogenesis and angiogenesis were detected by immunofluorescence double labeling method. The expression level of miR-199a-5p was tested by real-time RT-PCR, and the protein expressions of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) were determined by Western blotting.
RESULTS: BYHWD treatment significantly promoted the recovery of neurological function (P<0.05 or P<0.01), reduced the infarct volume (P<0.05), increased the number of BrdU+/DCX+, BrdU+/NeuN+ and BrdU+/vWF+ cells (all P<0.01), upregulated the expression of miR-199a-5p (P<0.01), and increased the protein expression of VEGF and BDNF at d14 after cerebral ischemia (all P<0.05). The above effects were reversed by intracerebroventricular injection of miR-199a-5p antagomir.
CONCLUSIONS: Buyang Huanwu decoction promotes neurogenesis and angiogenesis in rats with cerebral ischemia, which may be related to increased protein expression of VEGF and BDNF through upregulating miR-199a-5p.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences - 49(2020), 6 vom: 25. Dez., Seite 687-696 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Zhuge, Lujie [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.01.2021 Date Revised 12.08.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.3785/j.issn.1008-9292.2020.12.03 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320113906 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320113906 | ||
003 | DE-627 | ||
005 | 20231225172904.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.3785/j.issn.1008-9292.2020.12.03 |2 doi | |
028 | 5 | 2 | |a pubmed24n1067.xml |
035 | |a (DE-627)NLM320113906 | ||
035 | |a (NLM)33448171 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Zhuge, Lujie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chinese medicine Buyang Huanwu decoction promotes neurogenesis and angiogenesis in ischemic stroke rats by upregulating miR-199a-5p expression |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.01.2021 | ||
500 | |a Date Revised 12.08.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To investigate the mechanism of Chinese medicine Buyang Huanwu decoction (BYHWD) promoting neurogenesis and angiogenesis in ischemic stroke rats | ||
520 | |a METHODS: Male SD rats were randomly divided into sham operation group, model group, BYHWD group, antagonist group and antagonist control group with 14 rats in each. Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery for 90 min with intraluminal filament and reperfusion for 14 d in all groups except sham operation group. BYHWD (13 g/kg) was administrated by gastrogavage in BYHWD group, antagonist group and antagonist control group at 24 h after modeling respectively, and BrdU (50 mg/kg) was injected intraperitoneally in all groups once a day for 14 consecutive days. miR-199a-5p antagomir or NC (10 nmol) was injected into the lateral ventricle at d5 after ischemia in antagonist and antagonist control groups, respectively. The neurological deficits were evaluated by the modified neurological severity score (mNSS) and the corner test, and the infract volume was measured by toluidine blue staining. Neurogenesis and angiogenesis were detected by immunofluorescence double labeling method. The expression level of miR-199a-5p was tested by real-time RT-PCR, and the protein expressions of vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) were determined by Western blotting | ||
520 | |a RESULTS: BYHWD treatment significantly promoted the recovery of neurological function (P<0.05 or P<0.01), reduced the infarct volume (P<0.05), increased the number of BrdU+/DCX+, BrdU+/NeuN+ and BrdU+/vWF+ cells (all P<0.01), upregulated the expression of miR-199a-5p (P<0.01), and increased the protein expression of VEGF and BDNF at d14 after cerebral ischemia (all P<0.05). The above effects were reversed by intracerebroventricular injection of miR-199a-5p antagomir | ||
520 | |a CONCLUSIONS: Buyang Huanwu decoction promotes neurogenesis and angiogenesis in rats with cerebral ischemia, which may be related to increased protein expression of VEGF and BDNF through upregulating miR-199a-5p | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Angiogenesis | |
650 | 4 | |a Buyang Huanwu decoction | |
650 | 4 | |a Cerebral ischemia | |
650 | 4 | |a Neurogenesis | |
650 | 4 | |a Rats, Sprague-Dawley | |
650 | 4 | |a miR-199a-5p | |
650 | 4 | |a microRNA | |
650 | 7 | |a Dcx protein, rat |2 NLM | |
650 | 7 | |a Doublecortin Protein |2 NLM | |
650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
650 | 7 | |a MIRN199 microRNA, rat |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
650 | 7 | |a buyang huanwu |2 NLM | |
700 | 1 | |a Fang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Jin, Huaqian |e verfasserin |4 aut | |
700 | 1 | |a Li, Lin |e verfasserin |4 aut | |
700 | 1 | |a Yang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Hu, Xiaowei |e verfasserin |4 aut | |
700 | 1 | |a Chu, Lisheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences |d 2002 |g 49(2020), 6 vom: 25. Dez., Seite 687-696 |w (DE-627)NLM123207037 |x 1008-9292 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2020 |g number:6 |g day:25 |g month:12 |g pages:687-696 |
856 | 4 | 0 | |u http://dx.doi.org/10.3785/j.issn.1008-9292.2020.12.03 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2020 |e 6 |b 25 |c 12 |h 687-696 |